1. Home
  2. CTXR vs GFAI Comparison

CTXR vs GFAI Comparison

Compare CTXR & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • GFAI
  • Stock Information
  • Founded
  • CTXR 2007
  • GFAI 2018
  • Country
  • CTXR United States
  • GFAI Singapore
  • Employees
  • CTXR N/A
  • GFAI N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • GFAI Diversified Commercial Services
  • Sector
  • CTXR Health Care
  • GFAI Consumer Discretionary
  • Exchange
  • CTXR Nasdaq
  • GFAI Nasdaq
  • Market Cap
  • CTXR 21.6M
  • GFAI 23.3M
  • IPO Year
  • CTXR N/A
  • GFAI N/A
  • Fundamental
  • Price
  • CTXR $1.67
  • GFAI $1.32
  • Analyst Decision
  • CTXR Strong Buy
  • GFAI Strong Buy
  • Analyst Count
  • CTXR 3
  • GFAI 1
  • Target Price
  • CTXR $53.00
  • GFAI $4.50
  • AVG Volume (30 Days)
  • CTXR 1.5M
  • GFAI 722.6K
  • Earning Date
  • CTXR 08-11-2025
  • GFAI 09-23-2025
  • Dividend Yield
  • CTXR N/A
  • GFAI N/A
  • EPS Growth
  • CTXR N/A
  • GFAI N/A
  • EPS
  • CTXR N/A
  • GFAI N/A
  • Revenue
  • CTXR N/A
  • GFAI $36,347,373.00
  • Revenue This Year
  • CTXR N/A
  • GFAI $5.66
  • Revenue Next Year
  • CTXR N/A
  • GFAI $4.69
  • P/E Ratio
  • CTXR N/A
  • GFAI N/A
  • Revenue Growth
  • CTXR N/A
  • GFAI 0.18
  • 52 Week Low
  • CTXR $0.65
  • GFAI $0.76
  • 52 Week High
  • CTXR $26.25
  • GFAI $3.88
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 56.18
  • GFAI 55.97
  • Support Level
  • CTXR $1.40
  • GFAI $1.27
  • Resistance Level
  • CTXR $1.67
  • GFAI $1.48
  • Average True Range (ATR)
  • CTXR 0.18
  • GFAI 0.10
  • MACD
  • CTXR -0.03
  • GFAI 0.01
  • Stochastic Oscillator
  • CTXR 36.90
  • GFAI 50.00

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

Share on Social Networks: